Accrued expenses consisted of the following (in thousands):
June 30,
December 31,
2026
2025
Personnel costs
$
10,212
14,534
Clinical trial costs
5,516
4,011
Professional fees, contingencies and legal fees
5,780
5,160
Sales chargebacks, rebates and other revenue reserves
61
62
Other
428
627
Total accrued expenses
21,997
24,394
No definition available.
Tabular disclosure of the components of accrued liabilities.